Literature DB >> 1311724

Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity.

R A Zager1, C A Foerder.   

Abstract

Recent in vivo studies suggest that heme Fe causes proximal tubular lipid peroxidation and cytotoxicity, thereby contributing to the pathogenesis of myoglobinuric (Mgb) acute renal failure. Because hydroxyl radical (.OH) scavengers [dimethylthiourea (DMTU), benzoate, mannitol] can mitigate this injury, it is postulated that .OH is a mediator of Mgb-induced renal damage. The present study has tested these hypotheses using an isolated rat proximal tubular segment (PTS) system. An equal mixture of Fe2+/Fe3+ (4 mM total), when added to PTS, caused marked cytotoxicity [as defined by lactate dehydrogenase (LDH) release] and lipid peroxidation [assessed by malondialdehyde (MDA) increments]. Fe2+ or Fe3+ alone each induced massive MDA elevations, but only Fe2+ caused cytotoxicity. Although both DMTU and benzoate decreased LDH release during the Fe2+/Fe3+ challenge, mannitol and GSH did not, despite equivalent reductions in .OH (gauged by the salicylate trap method). GSH and catalase (but not DMTU, benzoate, or mannitol) decreased MDA concentrations, suggesting the Fe-driven lipid peroxidation was more H2O2 than .OH dependent. Deferoxamine totally blocked Fe-induced LDH release, even under conditions in which it caused an apparent increase in .OH generation. Mgb paradoxically protected against Fe-mediated PTS injury, an effect largely reproduced by albumin. In conclusion, these data suggest that: (a) Fe can cause PTS lipid peroxidation and cytotoxicity by a non-.OH-dependent mechanism; (b) Fe-mediated cytotoxicity and lipid peroxidation are not necessarily linked; and (c) Mgb paradoxically protects PTS against Fe-mediated injury, suggesting that: (i) Mgb Fe may require liberation from its porphyrin ring before exerting toxicity; and (ii) the protein residue may blunt the resulting injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311724      PMCID: PMC442948          DOI: 10.1172/JCI115682

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Experimental studies of acute renal failure. I. The protective effect of mannitol.

Authors:  W L PARRY; J A SCHAEFER; C B MUELLER
Journal:  J Urol       Date:  1963-01       Impact factor: 7.450

2.  Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury.

Authors:  R A Zager
Journal:  Lab Invest       Date:  1989-05       Impact factor: 5.662

3.  Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron.

Authors:  J M Gutteridge; Y Y Hou
Journal:  Free Radic Res Commun       Date:  1986

4.  Physical methods for the study of myoglobin.

Authors:  T M Rothgeb; F R Gurd
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

5.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

Authors:  M Mihara; M Uchiyama
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

6.  Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products.

Authors:  R A Floyd; J J Watson; P K Wong
Journal:  J Biochem Biophys Methods       Date:  1984-12

7.  Role of iron in postischemic renal injury in the rat.

Authors:  M S Paller; B E Hedlund
Journal:  Kidney Int       Date:  1988-10       Impact factor: 10.612

8.  The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron.

Authors:  J R Bucher; M Tien; S D Aust
Journal:  Biochem Biophys Res Commun       Date:  1983-03-29       Impact factor: 3.575

9.  Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules.

Authors:  J M Weinberg; J A Davis; M Abarzua; T Rajan
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

10.  Oxygen free radical involvement in ischemia and reperfusion injury to brain.

Authors:  W Cao; J M Carney; A Duchon; R A Floyd; M Chevion
Journal:  Neurosci Lett       Date:  1988-05-26       Impact factor: 3.046

View more
  12 in total

1.  Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.

Authors:  Richard A Zager
Journal:  Transl Res       Date:  2015-06-10       Impact factor: 7.012

2.  Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.

Authors:  Yingfeng Shi; Liuqing Xu; Jinhua Tang; Lu Fang; Shuchen Ma; Xiaoyan Ma; Jing Nie; Xiaoling Pi; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

3.  Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.

Authors:  R A Zager; B A Schimpf; C R Bredl; D J Gmur
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

4.  Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications.

Authors:  R A Zager
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Urine catalytic iron and neutrophil gelatinase-associated lipocalin as companion early markers of acute kidney injury after cardiac surgery: a prospective pilot study.

Authors:  Krittapoom Akrawinthawong; Michael K Shaw; Joshua Kachner; Eugene O Apostolov; Alexie G Basnakian; Sudhir Shah; Jacqueline Tilak; Peter A McCullough
Journal:  Cardiorenal Med       Date:  2013-02-06       Impact factor: 2.041

Review 6.  Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.

Authors:  Nadezda Petejova; Arnost Martinek
Journal:  Crit Care       Date:  2014-05-28       Impact factor: 9.097

7.  Acute Alcohol Intoxication Exacerbates Rhabdomyolysis-Induced Acute Renal Failure in Rats.

Authors:  Jen-Pi Tsai; Chung-Jen Lee; Yi-Maun Subeq; Ru-Ping Lee; Bang-Gee Hsu
Journal:  Int J Med Sci       Date:  2017-06-23       Impact factor: 3.738

8.  Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.

Authors:  Shifeng Zhao; Xueqiao Wang; Xiaoqing Zheng; Xiu Liang; Zhigang Wang; Juanlian Zhang; Xudong Zhao; Shougang Zhuang; Qiuhui Pan; Fenyong Sun; Wenjun Shang; Jonathan Barasch; Andong Qiu
Journal:  Free Radic Biol Med       Date:  2021-07-21       Impact factor: 8.101

9.  Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury.

Authors:  Kento Nishida; Hiroshi Watanabe; Shigeru Ogaki; Azusa Kodama; Ryota Tanaka; Tadashi Imafuku; Yu Ishima; Victor Tuan Giam Chuang; Masao Toyoda; Masumi Kondoh; Qiong Wu; Masafumi Fukagawa; Masaki Otagiri; Toru Maruyama
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  Renal Replacement Therapy in Acute Kidney Failure due to Rhabdomyolysis.

Authors:  G Maggi; F Quinteros Hinojosa; M J Villagran; E Guasch Arévalo; F Gilsanz Rodríguez
Journal:  Case Rep Crit Care       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.